Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis

被引:110
|
作者
Soini, Y
Salo, T
Satta, J
机构
[1] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Dept Diagnost & Oral Med, FIN-90014 Oulu, Finland
[3] Oulu Univ Hosp, Dept Cardiothorac Surg, Oulu, Finland
关键词
aortic valve; angiogenesis; vascular endothelial growth factor; nitric oxide synthase;
D O I
10.1016/S0046-8177(03)00245-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Angiogenesis is an essential biological process not only in embryogenesis, but also in the progression of several major diseases, including cancer, diabetes, and inflammation. Excessive vascularization can also contribute to some cardiovascular pathologies, such as atherosclerosis, but contradictory reports still prevail regarding its impact on aortic stenosis. Using immunohistochemical techniques, we assessed the vascular density and distribution of angiogenesis (FVIII) and vascular endothelial growth factor (VEGF) expression as well as the expression of 2 VEGF receptors, Flt-1 and Flk-1, in 55 nonrheumatic and 6 control aortic valves. In the light of the fact that the angiogenic effect of VEGF is mediated by sustained formation of nitric oxide, the samples were also immunostained with 3 nitric oxide synthase (eNOS, iNOS, and nNOS) antibodies. The immunohistochemical findings of VEGF and its receptors were verified by immunoblotting techniques. Vascular density was highest in the cases with moderate valve stenosis, and the mean number of FVIII-positive blood vessels was 1.7 +/- 1.9 vessels/mm(2) in the diseased valves, whereas the normal valves contained no blood vessels. Vascular density was significantly higher in the cases showing chronic inflammation (P = 0.007). Interestingly, the patients receiving statin therapy had significantly lower vascular densities than those not receiving such therapy (P = 0.001). Diseased valves showed distinct VEGF, Flt-1, Flk-1, and eNOS positivity of activated endothelial, stromal fusiform myofibroblastic, and histocytic cells. In contrast, immunoreactivity for iNOS and nNOS was seen only in nonendothelial stromal cells, and their expression was weaker. Enhanced vascular density was significantly associated with increased expression of Flk-1 (P = 0.028 for endothelial and P = 0.009 for stromal cells) and with endothelial eNOS expression (P 0.024). A similar tendency was also observed for VEGF, but not for Flt-1. Our results show a distinct angiogenic response and the presence of angiogenic factors in nonrheumatic aortic valve stenosis, suggesting that angiogenesis may influence on the evolution of this disease. Hum PATHOL 34:756-763. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 50 条
  • [1] In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis
    Toutouzas, Konstantinos
    Drakopoulou, Maria
    Synetos, Andreas
    Tsiamis, Eleftherios
    Agrogiannis, George
    Kavantzas, Nikolaos
    Patsouris, Eustratios
    Iliopoulos, Dimitris
    Theodoropoulos, Stergios
    Yacoub, Magdi
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (09) : 758 - 763
  • [2] Increased serum neopterin in patients with nonrheumatic aortic valve stenosis
    Naito, Yoshiro
    Tsujino, Takeshi
    Akahori, Hirokuni
    Matsumoto, Mika
    Ohyanagi, Mitsumasa
    Mitsuno, Masataka
    Miyamoto, Yuji
    Masuyama, Tohru
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (02) : 360 - 361
  • [3] Pathogenesis of calcific aortic valve stenosis
    Kaden, Jens J.
    HERZ, 2006, 31 (07) : 620 - 628
  • [4] Increased interleukin-18 expression in nonrheumatic aortic valve stenosis
    Naito, Yoshiro
    Tsujino, Takeshi
    Wakabayashi, Kana
    Matsumoto, Mika
    Ohyanagi, Mitsumasa
    Mitsuno, Masataka
    Miyamoto, Yuji
    Hao, Hiroyuki
    Hirota, Seiichi
    Okamura, Haruki
    Masuyama, Tohru
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (02) : 260 - 263
  • [5] Effect of aortic valve replacement on C-reactive protein in nonrheumatic aortic stenosis
    Gerber, IL
    Stewart, RAH
    Hammett, CJK
    Legget, ME
    Oxenham, H
    West, TM
    French, JK
    White, HD
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (09): : 1129 - 1132
  • [6] An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis
    Lewis, Christopher T. A.
    Mascall, Keith S.
    Wilson, Heather M.
    Murray, Fiona
    Kerr, Keith M.
    Gibson, George
    Buchan, Keith
    Small, Gary R.
    Nixon, Graeme F.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2023, 174 : 25 - 37
  • [7] Pathogenesis of aortic valve stenosis: a spectroscopic study
    Mamarelis, I.
    Pissaridi, K.
    Koutoulakis, E.
    Dritsa, V.
    Kotoulas, C. H.
    Mamareli, V.
    Anastassopoulou, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 699 - 699
  • [8] Pathogenesis and pathophysiology of aortic valve stenosis in adults
    Olszowska, Maria
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (11): : 409 - 412
  • [9] Expression of interleukin-33 and ST2 in nonrheumatic aortic valve stenosis
    Sawada, Hisashi
    Naito, Yoshiro
    Hirotani, Shinichi
    Akahori, Hirokuni
    Iwasaku, Toshihiro
    Okuhara, Yoshitaka
    Miki, Kojiro
    Eguchi, Akiyo
    Mitsuno, Masataka
    Miyamoto, Yuji
    Ohyanagi, Mitsumasa
    Tsujino, Takeshi
    Masuyama, Tohru
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 529 - 531
  • [10] Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis
    De Vecchis, Renato
    Di Biase, Giuseppina
    Esposito, Claudia
    Ciccarelli, Antonio
    Cioppa, Carmela
    Giasi, Anna
    Ariano, Carmelina
    Cantatrione, Salvatore
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (08) : 559 - 567